On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on PRs and Gain Exclusive Benefits with NNW Prime! Click to View Details
FridayFeb 02, 2018 12:27 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Agreement with Cannabis-Infused Edibles Manufacturer

Lexaria enters agreement with Cannfections to develop an innovative range of cannabis-infused chocolates and gummies incorporating its proprietary technology, DehydraTECH™ Cannfection’s formulation and manufacturing expertise can be offered to other Lexaria licensee partners The agreement is expected to generate new cannabis-based edible products for domestic and international markets On January 25, 2018, Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announced that it had entered into a seven-year agreement with Cannfections Group Inc. to provide its patented DehydraTECH™ technology for the development of a new range of cannabis-infused chocolates and gummies (http://nnw.fm/9DgLc). Cannfections is a new company, established by one of…

Continue Reading

FridayFeb 02, 2018 9:40 am

Sunniva, Inc. (CSE: SNN) Begins Trading on the Canadian Stock Exchange

SNN is a vertically integrated medial cannabis company operating in California and Canada Company's goal is to increase shareholder value by boosting stock liquidity and increasing exposure to investors SNN has a number of subsidiaries, including Sunniva Medical, Inc., CP Logistics, LLC, Natural Health Services Ltd., and Full Scale Distributors, LLC Sunniva, Inc., (CSE: SNN) began trading on the Canadian Stock Exchange under the ticker symbol "SNN" in early January, it announced (http://nnw.fm/TS7Ia). The company is a North American provider of medical cannabis products and services. SNN is a vertically integrated medical cannabis company operating in California and Canada, both…

Continue Reading

ThursdayFeb 01, 2018 3:57 pm

Pivot Pharmaceuticals Inc. (PVOTF) is “One to Watch”

Transdermal cannabis-based therapy promises greater absorption, less side effects Global medical marijuana market projected to reach $55.8 billion U.S. by 2025 Novel CBD delivery method targets array of unmet healthcare needs Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.…

Continue Reading

ThursdayFeb 01, 2018 3:29 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Teams with UniQuest to Develop Novel Cannabinoid Delivery System

Global nasal drug delivery technology market expected to reach $64 billion by 2021 Development of CBD-infused soluble gel for nasal delivery targets range of diseases Clinical benefits of Sol-gel delivery method include a safer, more reliable delivery platform with higher efficacy Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and UniQuest Pty Limited, the main commercialization company of the University of Queensland (UQ), Australia, are expecting 2018 to be an exciting, productive year for joint medical research projects. PreveCeutical Medical, headquartered in Vancouver, British Columbia, has entered into a research and option agreement with the University and…

Continue Reading

ThursdayFeb 01, 2018 2:18 pm

EVIO, Inc. (EVIO) Provides a Critical Service to the Regulated Cannabis Industry

EVIO is a leading accredited provider of analytical services to the regulated cannabis industry The company currently operates nine laboratories in five states EVIO is on track to open 18 labs around the U.S. by the end of 2018 EVIO, Inc. (OTCQB: EVIO) provides clients across the United States with consistent, high-quality cannabis analytical services. Backed by a stringent quality control assurance program, the company’s laboratory division, EVIO Labs, is the leading provider of accredited analytical testing, scientific research and advisory services to enterprises in the U.S. regulated cannabis industry. The ancillary services provided by EVIO Labs are state-mandated, requiring…

Continue Reading

ThursdayFeb 01, 2018 1:54 pm

Net Element, Inc. (NASDAQ: NETE) Attracts $7.55 Million Investment on Heels of Blockchain Initiative

Blockchain-focused business unit launched to create crypto-based ecosystem connecting merchants and consumers Cryptocurrency and blockchain technology applications market could reach $10 trillion by 2033 Institutional investment of $7.55 million will support blockchain initiatives and continued growth Net Element (NASDAQ: NETE), a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices, recently announced that it has completed a $7.55 million private placement of restricted common stock and warrants with a New York-based office that has made several investments in blockchain technology platforms. Shares of Net Element rose…

Continue Reading

ThursdayFeb 01, 2018 1:25 pm

NetworkNewsWire (NNW) Prime Introduces Total News Coverage Solution coupled with Discounted Press Release Services

NNW Prime member benefits include unlimited-word press releases to top-tier networks, third-party media coverage, high-level news enhancement, and more NEW YORK – February 1, 2018 (Globe Newswire) – via NetworkWire – NetworkNewsWire (NNW), a multifaceted financial news and publishing company, today announces the launch of its NetworkNewsWire Prime program designed to provide private and public companies access to core corporate communications solutions through a unique, discounted membership model. Top Benefits of NNW Prime Membership 20% off U.S. State & Local, U.S. National and Canadian distribution via NetworkWire Professional, in-house press release enhancement Team to ensure maximum impact Third-party media coverage…

Continue Reading

ThursdayFeb 01, 2018 12:04 pm

Golden Leaf Holdings, Ltd. (OTCQB: GLDFF) (CSE: GLH) Subsidiary Receives First Genetics at Ontario Plant-Growing Facility

Company plans mid-2018 commencement of adult-use market sales in Canada as it addresses medical segment opportunity The firm received its cultivation license during the fourth quarter of 2017, anticipates receiving its sales license by May Phillip Millar, MMG president, said company’s portfolio includes genetic strain that holds the highest level of CBD in Canada, sees potential in medical segment and for European export Golden Leaf Holdings, Ltd. (OTCQB: GLDFF) (CSE: GLH) recently announced that its subsidiary, Medical Marijuana Group ("MMG"), has received its first order of genetics at its St. Thomas, Ontario facility as it transitions from a production location…

Continue Reading

ThursdayFeb 01, 2018 9:00 am

Promising New Approaches in Pain Management

NetworkNewsWire Editorial Coverage: Pain is a wide-ranging complex medical condition that can be both physically debilitating and mentally destabilizing. Whether acute or chronic, caused by disease, trauma or neural damage, current pain therapeutics primarily rely on a variety of opioid-based pharmacological therapies that have ignited a severe public health crisis. The rampant dependency and abuse of opioid-based drugs has triggered a global quest for effective opioid free medications. Societal demands and sheer market size have bio-pharmaceutical companies searching for solutions to address the critical need for new ways to successfully treat pain. Establishing a new paradigm in pain management solutions,…

Continue Reading

ThursdayFeb 01, 2018 9:00 am

Artificial Intelligence Shakes-Up Fintech

NetworkNewsWire Editorial Coverage: Artificial intelligence (“AI”) is an increasingly important part of the financial technology sector, specifically in analyzing stocks and providing insights into the markets that human analysts alone can’t make. As such, AI-driven funds hold an increasingly large portion of the market, moving this technology into the mainstream. The result is a large opportunity for investors using this technology or investing in the companies producing it. Significant steps are being taken by companies such as AnalytixInsight (TSX.V: ALY) (OTCQB: ATIXF) (ATIXF Profile), whose flagship CapitalCube cloud-based analytics empowers investors to evaluate the potential of companies and portfolios. Other…

Continue Reading

Contact us: 212.418.1217